In early June 2026, the Directorate General of Foreign Trade (DGFT) issued a revised circular mandating annual independent audit of Import-Export Code (IEC) holders in the chemical and pharmaceutical sectors. This follows two years of pilot enforcement against undisclosed regulatory non-compliance among exporters.
The new requirement affects active IEC holders shipping chemicals, intermediates, APIs and formulations, and carries implications for record-keeping, third-party certification timelines and potential suspension risk for non-compliance.
Market signals
DGFT's June 2026 circular mandates that all active IEC holders in pharma and chemicals sectors commission an independent annual audit by a Chartered Accountant or Company Secretary, submitted within 30 days of financial year-end. Non-submission triggers IEC suspension after a 45-day cure period.
Exporters must now formally declare any pending or resolved CDSCO, FSSAI, state pollution board, or labour department actions as part of annual IEC renewal. False or incomplete disclosures attract enhanced penalties and potential permanent cancellation.
Beginning July 2026, DGFT systems will conduct monthly automated cross-checks between declared IEC shipments, GST e-invoice records, and bank-reported Foreign Inward Remittance Certificates (FIRCs). Material mismatches flag accounts for manual audit and potential IEC de-activation.
Under the revised DGFT circular (effective 1 June 2026), all IEC holders in the pharma and chemical sector must now obtain annual audit certification and file disclosure affidavits with their renewal applications. Failure to submit audit reports within the prescribed window results in IEC suspension, which halts export transactions and may trigger GST input-tax complications. Vinayakam Consultants assists clients in structuring compliance documentation, coordinating third-party audit engagement, and filing timely disclosures with DGFT to maintain uninterrupted export licensing. We also support clients in remedying historical non-disclosure issues before renewal deadlines to avoid cancellation risk.
Your action checklist
- Identify your financial year-end and commission a Chartered Accountant or Company Secretary to conduct IEC audit within 30 days post-FY closure; retain audit certificate and file with next annual IEC renewal application.
- Conduct internal audit of all regulatory interactions (CDSCO approvals, FSSAI clearances, environmental board consents, labour inspections) in the past 36 months and prepare a signed disclosure affidavit for IEC renewal; attach copies of all remedial orders or closure certificates.
- Reconcile your GST e-invoice records, export FIRCs and bank statements against declared shipment values in your IEC file; flag and correct any material discrepancies before July 2026 monthly DGFT-GST cross-checks commence.
- Brief your finance and compliance teams on the new annual audit and disclosure requirements, confirm audit-engagement timelines with your CA/CS firm, and set internal calendar reminders for IEC renewal filing 60 days before expiry to allow time for audit completion.
Frequently asked questions
Yes, DGFT's June 2026 circular mandates all active IEC holders in pharma and chemicals sectors to commission an independent annual audit by a Chartered Accountant or Company Secretary, submitted within 30 days of financial year-end.
Non-submission triggers IEC suspension after a 45-day cure period. You must also declare any pending or resolved regulatory non-compliance (CDSCO, FSSAI, pollution board, labour) during IEC renewal or face enhanced penalties and potential permanent cancellation.
Beginning July 2026, DGFT systems conduct monthly automated cross-checks between declared IEC shipments, GST e-invoice records, and FIRCs. Material mismatches flag accounts for manual audit and potential IEC de-activation.